BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 27865784)

  • 21. Direct comparison of QIAamp DSP Virus Kit and QIAamp Circulating Nucleic Acid Kit regarding cell-free fetal DNA isolation from maternal peripheral blood.
    Jain M; Balatsky AV; Revina DB; Samokhodskaya LM
    Mol Cell Probes; 2019 Feb; 43():13-19. PubMed ID: 30584912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimizing the yield and utility of circulating cell-free DNA from plasma and serum.
    Xue X; Teare MD; Holen I; Zhu YM; Woll PJ
    Clin Chim Acta; 2009 Jun; 404(2):100-4. PubMed ID: 19281804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimization of Sources of Circulating Cell-Free DNA Variability for Downstream Molecular Analysis.
    Till JE; Black TA; Gentile C; Abdalla A; Wang Z; Sangha HK; Roth JJ; Sussman R; Yee SS; O'Hara MH; Thompson JC; Aggarwal C; Hwang WT; Elenitoba-Johnson KSJ; Carpenter EL
    J Mol Diagn; 2021 Nov; 23(11):1545-1552. PubMed ID: 34454115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A modified extraction method of circulating free DNA for epidermal growth factor receptor mutation analysis.
    Yuan H; Zhu ZZ; Lu Y; Liu F; Zhang W; Huang G; Zhu G; Jiang B
    Yonsei Med J; 2012 Jan; 53(1):132-7. PubMed ID: 22187243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Four Commercial Kits for Isolation of Urinary Cell-Free DNA and Sample Storage Conditions.
    Lee EY; Lee EJ; Yoon H; Lee DH; Kim KH
    Diagnostics (Basel); 2020 Apr; 10(4):. PubMed ID: 32325682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levels of cell-free DNA and plasma KRAS during treatment of advanced NSCLC.
    Dowler Nygaard A; Spindler KL; Pallisgaard N; Andersen RF; Jakobsen A
    Oncol Rep; 2014 Feb; 31(2):969-74. PubMed ID: 24316734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in mutational status during third-line treatment for metastatic colorectal cancer--results of consecutive measurement of cell free DNA, KRAS and BRAF in the plasma.
    Spindler KL; Pallisgaard N; Andersen RF; Jakobsen A
    Int J Cancer; 2014 Nov; 135(9):2215-22. PubMed ID: 24659028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liquid biopsy in colon cancer: comparison of different circulating DNA extraction systems following absolute quantification of
    Kloten V; Rüchel N; Brüchle NO; Gasthaus J; Freudenmacher N; Steib F; Mijnes J; Eschenbruch J; Binnebösel M; Knüchel R; Dahl E
    Oncotarget; 2017 Oct; 8(49):86253-86263. PubMed ID: 29156792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell-free DNA as biomarker and source for mutation detection in primary colorectal cancer.
    Nikolic A; Vlajnic M; Ristanovic M; Petrovic J; Dimitrijevic I; Krivokapic Z; Radojkovic D
    J BUON; 2017; 22(1):178-183. PubMed ID: 28365952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating tumor DNA in unresectable pancreatic cancer is a strong predictor of first-line treatment efficacy: The KRASCIPANC prospective study.
    Evrard C; Ingrand P; Rochelle T; Martel M; Tachon G; Flores N; Randrian V; Ferru A; Haineaux PA; Goujon JM; Karayan-Tapon L; Tougeron D
    Dig Liver Dis; 2023 Nov; 55(11):1562-1572. PubMed ID: 37308396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma vs. serum in circulating tumor DNA measurement: characterization by DNA fragment sizing and digital droplet polymerase chain reaction.
    Lee JS; Kim M; Seong MW; Kim HS; Lee YK; Kang HJ
    Clin Chem Lab Med; 2020 Mar; 58(4):527-532. PubMed ID: 31874093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-throughput and affordable genome-wide methylation profiling of circulating cell-free DNA by methylated DNA sequencing (MeD-seq) of LpnPI digested fragments.
    Deger T; Boers RG; de Weerd V; Angus L; van der Put MMJ; Boers JB; Azmani Z; van IJcken WFJ; Grünhagen DJ; van Dessel LF; Lolkema MPJK; Verhoef C; Sleijfer S; Martens JWM; Gribnau J; Wilting SM
    Clin Epigenetics; 2021 Oct; 13(1):196. PubMed ID: 34670587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of KRAS Mutations in Circulating Tumor DNA by Digital PCR in Early Stages of Pancreatic Cancer.
    Brychta N; Krahn T; von Ahsen O
    Clin Chem; 2016 Nov; 62(11):1482-1491. PubMed ID: 27591291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating cell-free DNA as a prognostic and predictive biomarker in non-small cell lung cancer.
    Ai B; Liu H; Huang Y; Peng P
    Oncotarget; 2016 Jul; 7(28):44583-44595. PubMed ID: 27323821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic Implications of Multiplex Detection of
    Kim MK; Woo SM; Park B; Yoon KA; Kim YH; Joo J; Lee WJ; Han SS; Park SJ; Kong SY
    Clin Chem; 2018 Apr; 64(4):726-734. PubMed ID: 29352043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post surgery circulating free tumor DNA is a predictive biomarker for relapse of lung cancer.
    Hu W; Yang Y; Zhang L; Yin J; Huang J; Huang L; Gu H; Jiang G; Fang J
    Cancer Med; 2017 May; 6(5):962-974. PubMed ID: 28382702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective blinded study of somatic mutation detection in cell-free DNA utilizing a targeted 54-gene next generation sequencing panel in metastatic solid tumor patients.
    Kim ST; Lee WS; Lanman RB; Mortimer S; Zill OA; Kim KM; Jang KT; Kim SH; Park SH; Park JO; Park YS; Lim HY; Eltoukhy H; Kang WK; Lee WY; Kim HC; Park K; Lee J; Talasaz A
    Oncotarget; 2015 Nov; 6(37):40360-9. PubMed ID: 26452027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Study of Pre-Analytical Variables and Optimization of Extraction Method for Circulating Tumor DNA Measurements by Digital Droplet PCR.
    Cavallone L; Aldamry M; Lafleur J; Lan C; Gonzalez Ginestet P; Alirezaie N; Ferrario C; Aguilar-Mahecha A; Basik M
    Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):909-916. PubMed ID: 30824523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Qualitative and quantitative comparison of cell-free DNA and cell-free fetal DNA isolation by four (semi-)automated extraction methods: impact in two clinical applications: chimerism quantification and noninvasive prenatal diagnosis.
    Pedini P; Graiet H; Laget L; Filosa L; Chatron J; Cherouat N; Chiaroni J; Hubert L; Frassati C; Picard C
    J Transl Med; 2021 Jan; 19(1):15. PubMed ID: 33407582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Effect of Preservative and Temperature on the Analysis of Circulating Tumor DNA.
    Parpart-Li S; Bartlett B; Popoli M; Adleff V; Tucker L; Steinberg R; Georgiadis A; Phallen J; Brahmer J; Azad N; Browner I; Laheru D; Velculescu VE; Sausen M; Diaz LA
    Clin Cancer Res; 2017 May; 23(10):2471-2477. PubMed ID: 27827317
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.